2021 American Transplant Congress » Kidney Deceased Donor Selection

4:30pm-4:35pm

Findings from the Bareto Study: Associations Between Chronic Vascular Changes and 10-year Transplant Graft Outcomes

L. Kamal¹, D. Stewart², J. Foutz², H. McGehee², P. Saravanane¹, S. Yu¹, R. Yusfi¹, G. Gupta¹

4:35pm-4:40pm

An HLA Class II Matching Strategy That Predicts De Novo Donor-specific HLA Antibody Formation Using Low Resolution HLA Types

L. Hidalgo¹, I. Martinez Juarez², L. Morales Buenrostro², S. Shojai³, P. Campbell¹

4:40pm-4:45pm

Outcomes from High KDPI Kidneys Utilized for Dual Kidney Transplantation

J. Wagler¹, K. Mitchell², S. Ohara³, R. Heilman², S. K. Reddy², H. Khamash², C. Jadlowiec²

4:45pm-4:50pm

Successful Outcomes from Selected Akin3 Donors Requiring Renal Replacement: Avenue for Increase in Organ Utilization

P. Budhiraja¹, R. L. Heilman¹, M. L. Smith², H. A. Khamash¹, L. Kodali¹, A. A. Moss³, A. K. Mathur³, C. Jadlowiec³, K. S. Reddy³

4:55pm-5:00pm

Outcomes of Kidney Transplant Recipients (KTRs) Comparing Brain Dead Donors’ vs Donation After Cardiac Death Stratified by KDPI, Focus on Marginal Kidneys: A UNOS Database Analysis

B. Chopra¹, K. K. Sureshkumar¹, D. Rajasundaram², E. C. Rodrigo³

5:00pm-5:05pm

Expanding A₂ to B Kidney Transplantation: Safe and Effective Use of Recipients with High Titer Antibodies

A. Gilbert¹, S. Radomski², J. Verbesey¹, J. Vucci¹, M. Cooper¹

5:05pm-5:10pm

How Long is the Wait Worthwhile: Cost-Effectiveness of Accepting a Kidney from a Donor with Apolipoprotein L1 High-Risk Genotype

K. Lentine¹, D. Brennan², M. Wang³, M. Schnitzler⁴, H. Xiao⁴, D. Axelrod⁵, J. Snyder⁶, K. Lentine⁴